Arteris (NASDAQ: AIP) awards VP, GC 32,385 restricted stock units

Rhea-AI Filing Summary

Alpern Paul L reported acquisition or exercise transactions in this Form 4 filing.

Arteris, Inc. reported that its VP and General Counsel, Paul L. Alpern, received an equity award of 32,385 restricted stock units (RSUs), each representing one share of common stock, at no cash cost per share. These RSUs will vest as to 1/16 of the total on April 1, 2026, then in equal quarterly installments thereafter, and have no expiration date. Following this grant, Alpern beneficially owns 90,035 shares of common stock, including the 32,385 RSUs.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alpern Paul L

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP and General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		A(1)		32,385	A	$0.00	90,035	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 32,385 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 1/16th of the total RSUs on 4/1/2026 and in equal quarterly installments thereafter. The RSUs have no expiration date.

Remarks:

	/s/ Paul Alpern	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Arteris (AIP) report for Paul L. Alpern?

Arteris reported that VP and General Counsel Paul L. Alpern acquired 32,385 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Arteris common stock, awarded at no cash cost per share as equity compensation.

How many Arteris (AIP) shares does Paul L. Alpern own after this Form 4?

After this transaction, Paul L. Alpern beneficially owns 90,035 shares of Arteris common stock. This figure includes 32,385 restricted stock units, each convertible into one share upon vesting, reflecting his updated total equity interest.

What are the vesting terms of the 32,385 RSUs granted by Arteris (AIP)?

The 32,385 RSUs vest over time, with 1/16 of the total vesting on April 1, 2026. The remaining RSUs then vest in equal quarterly installments thereafter, aligning the award with continued service over multiple vesting dates.

Do the Arteris (AIP) RSUs granted to Paul L. Alpern have an expiration date?

The RSUs granted to Paul L. Alpern have no expiration date. Each RSU remains outstanding until it either vests and converts into one share of Arteris common stock or is otherwise forfeited under the applicable award terms.

Was the Arteris (AIP) RSU grant to Paul L. Alpern a market purchase?

No. The transaction is coded as a grant or award acquisition, not a market purchase. Alpern received 32,385 restricted stock units at a reported price of $0.0000 per share as part of his equity compensation package.